ArticleFrontiers in cell and developmental biology2026
Altered brain vascularization and transcriptional changes in embryos lacking ABCA1 support a role of cholesterol in brain angiogenesis.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lipoproteins are the main lipid carriers in extracellular fluids and mediate the exchange of hydrophobic molecules between cells and their environment in animals, including cholesterol. Lipoprotein metabolism has been implicated in the regulation of angiogenesis, suggesting that cholesterol is important for this process, but a direct role for this lipid has not been unequivocally demonstrated, particularly in the central nervous system (CNS). Methods: Here, we used genetic and pharmacological models to address this issue in different models of CNS angiogenesis. Results: We show that inactivation of ABCA1, one of the main cholesterol efflux pumps, leads to altered brain vascularization and a longer angiogenic window, while inactivation of the bidirectional cholesterol transporter SR-B1 has no effect. These functional changes are accompanied by consistent transcriptomic changes in genes involved in cholesterol synthesis and angiogenesis. In support of the role of cholesterol, experimental reduction of this lipid in cultured brain endothelial cells leads to a transcriptomic signature showing the opposite direction in those genes. Discussion: These studies support a role for ABCA1 and cholesterol in regulating a trascriptional program governing angiogenesis in the brain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.